Evidence map›Paper›PMID 27242060›Full record

ArticleAIDS care2016

Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.

Mollie A Monnig, Christopher W Kahler, Patricia A Cioe, Lynne Tucker, Peter M Monti, Kenneth H Mayer, Bharat Ramratnam

Abstract read
In one paragraph

Article in AIDS care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa.International journal of environmental research and public health · 2021
    Article
  4. Review
  5. Article
  6. Effect of Opioid Use on Immune Activation and HIV Persistence on ART.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  7. Conventional Dendritic Cells and SlanFrontiers in immunology · 2020
    Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Altered Gut Microbiota in Myasthenia Gravis.Frontiers in microbiology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mollie A Monniga Center for Alcohol and Addiction Studies , School of Public Health, Brown University , Providence , RI , USA.
Christopher W Kahlera Center for Alcohol and Addiction Studies , School of Public Health, Brown University , Providence , RI , USA.
Patricia A Cioea Center for Alcohol and Addiction Studies , School of Public Health, Brown University , Providence , RI , USA.
Lynne Tuckerb Alcohol Research Center on HIV , Brown University , Providence , RI , USA.
Peter M Montia Center for Alcohol and Addiction Studies , School of Public Health, Brown University , Providence , RI , USA.
Kenneth H Mayerd The Fenway Institute, Fenway Health , Boston , MA , USA.
Bharat Ramratnamb Alcohol Research Center on HIV , Brown University , Providence , RI , USA.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Virology CoreP01AA019072 · NIAAA · BROWN UNIVERSITY · PI KAHLER, CHRISTOPHER W. · 2010 to 2024
$19.7M
ALCOHOL INTERVENTION/TREATMENT OUTCOME RESEARCH TRAININGT32AA007459 · NIAAA · BROWN UNIVERSITY · PI ROBERT MIRANDA, PETER M. MONTI · 1986 to 2026
$13.3M
COBRE Center for Cancer Research DevelopmentP30GM110759 · NIGMS · RHODE ISLAND HOSPITAL · PI RAMRATNAM, BHARAT · 2015 to 2019
$6.3M
Advancing a Bio-Psycho-Social Alcohol Treatment Research and Mentoring ProgramK05AA019681 · NIAAA · BROWN UNIVERSITY · PI MONTI, PETER M. · 2010 to 2014
$1.2M
Immune Activation and Neurodegeneration in HIV Infection and Heavy DrinkingK23AA024704 · NIAAA · BROWN UNIVERSITY · PI MONNIG, MOLLIE A · 2016 to 2021
$1.1M
Studies in HIV-1 Pathogenesis and TransmissionK24HD080539 · NICHD · RHODE ISLAND HOSPITAL · PI RAMRATNAM, BHARAT · 2014 to 2018
$807k
Cardiovascular Risk Perception and Wellness Perspectives in HIV-infected AdultsK23NR014951 · NINR · BROWN UNIVERSITY · PI CIOE, PATRICIA ANN · 2014 to 2016
$397k
NIAAA NIH HHS K05 AA019681NIAAA NIH HHS K23 AA024704NIAAA NIH HHS P01 AA019072NIAAA NIH HHS T32 AA007459NIAID NIH HHS P30 AI042853NICHD NIH HHS K24 HD080539NIGMS NIH HHS P30 GM110759NINR NIH HHS K23 NR014951
6 · The paper itself

Abstract

Independently, HIV infection and heavy alcohol use increase microbial translocation (MT) of gut products into systemic circulation. MT and consequent immune response have been linked to chronic inflammation and a host of negative health outcomes in individuals living with HIV. However, previous research has not systematically investigated the immune correlates of heavy drinking specifically within the HIV-positive population. This pilot study investigated MT and immune activation as a function of alcohol use in 21 HIV-positive men who met NIAAA criteria for heavy drinking. Participants averaged 46.7 ± 8.5 (mean ± standard deviation) years of age, 12.2 ± 9.2 years since HIV diagnosis, 337 ± 158 CD4 nadir, and 643 ± 245 current CD4 count. All participants were virologically suppressed on antiretroviral therapy. Data on alcohol use and immune function were collected at baseline and three-month follow-up. Plasma concentrations of markers of MT and immune activation (lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody immunoglobulin M (EndoCAb)) were measured using enzyme-linked immunosorbent assays. Generalized estimating equation models tested alcohol use variables as predictors of LPS, sCD14, and EndoCAb levels. Greater quantity and frequency of drinking significantly predicted higher sCD14 levels (p's < .01). Conversely, longer duration of abstinence from alcohol significantly predicted lower sCD14 levels (p < .001). These results remained significant after controlling for age, HIV duration, smoking status, current CD4 count, CD4 nadir, and antiretroviral drug type. In addition, participants with ≥50% relative reduction in drinks per week showed a significant decrease (p < .05) in sCD14 from baseline to three-month follow-up. This pilot study provides preliminary evidence that heavy drinking may increase a key inflammatory marker in HIV-infected individuals with suppressed infection.

Indexed as

Bacterial TranslocationAdultAlcohol AbstinenceAlcoholismAntibodies, BacterialBiomarkersCD4 Lymphocyte CountEndotoxinsEnzyme-Linked Immunosorbent AssayHIV InfectionsHumansImmunoglobulin MInflammationLipopolysaccharide ReceptorsLipopolysaccharidesMaleAntibodies, BacterialBiomarkerscore endotoxinEndotoxinsImmunoglobulin MLipopolysaccharide ReceptorsLipopolysaccharidesalcoholheavy drinkingHIV infectioninflammationmicrobial translocationsCD14

Identifiers

PMID27242060
PMCPMC5017898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.